OvaScience Reports Third Quarter 2015 Financial Results

Go back to OvaScience Reports Third Quarter 2015 Financial Results

Leerink Partners Downgrades OvaScience (OVAS) to Market Perform

November 9, 2015 6:18 AM EST

Leerink Partners downgraded OvaScience (NASDAQ: OVAS) from Outperform to Market Perform with a price target of $14.00 (from $16.00) on sluggish commercial uptake and lack of visibility.

Analyst Paul Matteis commented, "We are downgrading OVAS to Market Perform from Outperform and are reducing our PT to $14 from $16. OVAS recently... More